Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1.09B
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
20.6M
-
Shares change
-
-203K
-
Total reported value, excl. options
-
$477M
-
Value change
-
+$2.41M
-
Number of buys
-
34
-
Number of sells
-
-37
-
Price
-
$23.22
Significant Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q4 2018
79 filings reported holding ZLAB - Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share as of Q4 2018.
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.6M shares
of 1.09B outstanding shares and own 1.89% of the company stock.
Largest 10 shareholders include FMR LLC (5.81M shares), Segantii Capital Management Ltd (2.4M shares), BAMCO INC /NY/ (1.97M shares), ORBIMED ADVISORS LLC (1.75M shares), PRICE T ROWE ASSOCIATES INC /MD/ (950K shares), GILDER GAGNON HOWE & CO LLC (880K shares), Vanguard Group Inc (804K shares), Myriad Asset Management Ltd. (802K shares), Cormorant Asset Management, LP (787K shares), and EcoR1 Capital, LLC (569K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.